 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Nmc-a carbapenemase from enterobacter cloacae
|
|
Structure:
|
 |
Protein (imipenem-hydrolysing beta-lactamase). Chain: a. Synonym: carbapenemase, nmc-a. Engineered: yes
|
|
Source:
|
 |
Enterobacter cloacae. Organism_taxid: 550. Strain: nor-1. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.64Å
|
R-factor:
|
0.192
|
R-free:
|
0.214
|
|
|
Authors:
|
 |
P.Swaren,L.Maveyraud,S.Cabantous,J.D.Pedelacq,L.Mourey, J.M.Frere,J.P.Samama
|
Key ref:
|
 |
P.Swarén
et al.
(1998).
X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity.
J Biol Chem,
273,
26714-26721.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Sep-98
|
Release date:
|
02-Sep-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52663
(BLAN_ENTCL) -
Imipenem-hydrolyzing beta-lactamase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
292 a.a.
265 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
response to antibiotic
|
2 terms
|
 |
|
Biochemical function
|
hydrolase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
273:26714-26721
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity.
|
|
P.Swarén,
L.Maveyraud,
X.Raquet,
S.Cabantous,
C.Duez,
J.D.Pédelacq,
S.Mariotte-Boyer,
L.Mourey,
R.Labia,
M.H.Nicolas-Chanoine,
P.Nordmann,
J.M.Frère,
J.P.Samama.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The treatment of infectious diseases by penicillin and cephalosporin antibiotics
is continuously challenged by the emergence and the dissemination of the
numerous TEM and SHV mutant beta-lactamases with extended substrate profiles.
These class A beta-lactamases nevertheless remain inefficient against
carbapenems, the most effective antibiotics against clinically relevant
pathogens. A new member of this enzyme class, NMC-A, was recently reported to
hydrolyze at high rates, and hence destroy, all known beta-lactam antibiotics,
including carbapenems and cephamycins. The crystal structure of NMC-A was solved
to 1.64-A resolution, and reveals modifications in the topology of the
substrate-binding site. While preserving the geometry of the essential catalytic
residues, the active site of the enzyme presents a disulfide bridge between
residues 69 and 238, and certain other structural differences compared with the
other beta-lactamases. These unusual features in class A beta-lactamases involve
amino acids that participate in enzyme-substrate interactions, which suggested
that these structural factors should be related to the very broad substrate
specificity of this enzyme. The comparison of the NMC-A structure with those of
other class A enzymes and enzyme-ligand complexes, indicated that the position
of Asn-132 in NMC-A provides critical additional space in the region of the
protein where the poorer substrates for class A beta-lactamases, such as
cephamycins and carbapenems, need to be accommodated.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Chemical structures of the five classes of -lactam
antibiotics. The letters a, b, and c indicate kinetic data from
Refs. 16, 42, and 17, respectively. *, not measurable.
|
 |
Figure 5.
Fig. 5. Stereo view of the hydrogen bond pattern (dotted
lines) involving Arg-220 and His-274 in the NMC-A structure.
Water molecules are indicated by spheres.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1998,
273,
26714-26721)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.De Pascale,
and
G.D.Wright
(2010).
Antibiotic resistance by enzyme inactivation: from mechanisms to solutions.
|
| |
Chembiochem, 11,
1325-1334.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev, 23,
160-201.
|
 |
|
|
|
|
 |
E.Sauvage,
A.Zervosen,
G.Dive,
R.Herman,
A.Amoroso,
B.Joris,
E.Fonzé,
R.F.Pratt,
A.Luxen,
P.Charlier,
and
F.Kerff
(2009).
Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.
|
| |
J Am Chem Soc, 131,
15262-15269.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Hanes,
K.M.Jude,
J.M.Berger,
R.A.Bonomo,
and
T.M.Handel
(2009).
Structural and biochemical characterization of the interaction between KPC-2 beta-lactamase and beta-lactamase inhibitor protein.
|
| |
Biochemistry, 48,
9185-9193.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Sacha,
A.Ostas,
J.Jaworowska,
P.Wieczorek,
D.Ojdana,
J.Ratajczak,
and
E.Tryniszewska
(2009).
The KPC type beta-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli.
|
| |
Folia Histochem Cytobiol, 47,
537-543.
|
 |
|
|
|
|
 |
D.Meziane-Cherif,
D.Decré,
E.A.Høiby,
P.Courvalin,
and
B.Périchon
(2008).
Genetic and Biochemical Characterization of CAD-1, a Chromosomally Encoded New Class A Penicillinase from Carnobacterium divergens.
|
| |
Antimicrob Agents Chemother, 52,
551-556.
|
 |
|
|
|
|
 |
S.Petrella,
N.Ziental-Gelus,
C.Mayer,
M.Renard,
V.Jarlier,
and
W.Sougakoff
(2008).
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
|
| |
Antimicrob Agents Chemother, 52,
3725-3736.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.M.Queenan,
and
K.Bush
(2007).
Carbapenemases: the versatile beta-lactamases.
|
| |
Clin Microbiol Rev, 20,
440.
|
 |
|
|
|
|
 |
C.A.Smith,
M.Caccamo,
K.A.Kantardjieff,
and
S.Vakulenko
(2007).
Structure of GES-1 at atomic resolution: insights into the evolution of carbapenamase activity in the class A extended-spectrum beta-lactamases.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
982-992.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Fonseca,
A.C.Sarmento,
I.Henriques,
B.Samyn,
J.van Beeumen,
P.Domingues,
M.R.Domingues,
M.J.Saavedra,
and
A.Correia
(2007).
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
|
| |
Antimicrob Agents Chemother, 51,
4512-4514.
|
 |
|
|
|
|
 |
W.Ke,
C.R.Bethel,
J.M.Thomson,
R.A.Bonomo,
and
F.van den Akker
(2007).
Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.
|
| |
Biochemistry, 46,
5732-5740.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Wang,
C.Cassidy,
and
J.C.Sacchettini
(2006).
Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
|
| |
Antimicrob Agents Chemother, 50,
2762-2771.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.K.Majiduddin,
and
T.Palzkill
(2005).
Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
|
| |
Antimicrob Agents Chemother, 49,
3421-3427.
|
 |
|
|
|
|
 |
N.H.Georgopapadakou
(2004).
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
|
| |
Expert Opin Investig Drugs, 13,
1307-1318.
|
 |
|
|
|
|
 |
F.K.Majiduddin,
and
T.Palzkill
(2003).
Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
|
| |
Antimicrob Agents Chemother, 47,
1062-1067.
|
 |
|
|
|
|
 |
I.Massova,
and
P.A.Kollman
(2002).
pKa, MM, and QM studies of mechanisms of beta-lactamases and penicillin-binding proteins: acylation step.
|
| |
J Comput Chem, 23,
1559-1576.
|
 |
|
|
|
|
 |
M.Dumoulin,
K.Conrath,
A.Van Meirhaeghe,
F.Meersman,
K.Heremans,
L.G.Frenken,
S.Muyldermans,
L.Wyns,
and
A.Matagne
(2002).
Single-domain antibody fragments with high conformational stability.
|
| |
Protein Sci, 11,
500-515.
|
 |
|
|
|
|
 |
W.Sougakoff,
G.L'Hermite,
L.Pernot,
T.Naas,
V.Guillet,
P.Nordmann,
V.Jarlier,
and
J.Delettré
(2002).
Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
267-274.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Wang,
G.Minasov,
and
B.K.Shoichet
(2002).
Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
|
| |
Proteins, 47,
86-96.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Bebrone,
C.Moali,
F.Mahy,
S.Rival,
J.D.Docquier,
G.M.Rossolini,
J.Fastrez,
R.F.Pratt,
J.M.Frère,
and
M.Galleni
(2001).
CENTA as a chromogenic substrate for studying beta-lactamases.
|
| |
Antimicrob Agents Chemother, 45,
1868-1871.
|
 |
|
|
|
|
 |
D.Lim,
F.Sanschagrin,
L.Passmore,
L.De Castro,
R.C.Levesque,
and
N.C.Strynadka
(2001).
Insights into the molecular basis for the carbenicillinase activity of PSE-4 beta-lactamase from crystallographic and kinetic studies.
|
| |
Biochemistry, 40,
395-402.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Yigit,
A.M.Queenan,
G.J.Anderson,
A.Domenech-Sanchez,
J.W.Biddle,
C.D.Steward,
S.Alberti,
K.Bush,
and
F.C.Tenover
(2001).
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
|
| |
Antimicrob Agents Chemother, 45,
1151-1161.
|
 |
|
|
|
|
 |
I.Trehan,
B.M.Beadle,
and
B.K.Shoichet
(2001).
Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
|
| |
Biochemistry, 40,
7992-7999.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Vilar,
M.Galleni,
T.Solmajer,
B.Turk,
J.M.Frère,
and
A.Matagne
(2001).
Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.
|
| |
Antimicrob Agents Chemother, 45,
2215-2223.
|
 |
|
|
|
|
 |
L.Maveyraud,
D.Golemi,
L.P.Kotra,
S.Tranier,
S.Vakulenko,
S.Mobashery,
and
J.P.Samama
(2000).
Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa.
|
| |
Structure, 8,
1289-1298.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Bonnet,
J.L.Sampaio,
C.Chanal,
D.Sirot,
C.De Champs,
J.L.Viallard,
R.Labia,
and
J.Sirot
(2000).
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil.
|
| |
Antimicrob Agents Chemother, 44,
3061-3068.
|
 |
|
|
|
|
 |
S.Ness,
R.Martin,
A.M.Kindler,
M.Paetzel,
M.Gold,
S.E.Jensen,
J.B.Jones,
and
N.C.Strynadka
(2000).
Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
|
| |
Biochemistry, 39,
5312-5321.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|